Company / Return on Assets (ROA)
Adaptive Biotechnologies Corp Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-11.6%
FY2025
5-year range
-34.1% / -11.6%
FY2021-FY2025
Trend
+60.8%
vs FY2024
Sector context
#86 of 213
Health Care
What the data says
At -11.6%, Adaptive Biotechnologies Corp's return on assets (roa) ranks #86 of 213 in the Health Care sector. Improved from -34.1% to -11.6% over the past 2 years.
Based on SEC 10-K filings.
-11.6% in FY2025 with a 5-year CAGR of +1.5%.
Improved from -34.1% to -11.6% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +11.8pp
- 5-Year Change
- +1.5pp
- 10-Year Change
- -
Sector benchmark
#86 of 213 in Health CareTop 40% of 213This company -11.6% Sector average -24.2%
▼
+52.0% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 60.8% year-over-year.
- Currently 12.6pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2019.
- Lowest return on assets (roa) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -11.6% | +60.8% |
| FY2024 | -29.6% | +13.2% |
| FY2023 | -34.1% | -45.8% |
| FY2022 | -23.4% | -4.1% |
| FY2021 | -22.4% | -71.4% |
| FY2020 | -13.1% | -74.2% |
| FY2019 | -7.5% | +46.1% |
| FY2018 | -14.0% | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026